Professional Documents
Culture Documents
Fluorouracil
Tradename
Fluorouracil
Fluorouracile
Flurablastin
Fluracedyl
Fluroblastin
Fluroblastine
Stability in solutions
1,44 mg/ml
23C
72
1501
1,44 mg/ml
4C
72
1501
1,5 mg/ml
25C
56
840
5 mg/ml
2-8C
91
110
25C
13
39
4C
13
39
1 & 10 mg/ml
21C
14
1475
1 & 10 mg/ml
4C
14
1475
1,44 mg/ml
23C
72
1501
1,44 mg/ml
4C
72
1501
1,5 mg/ml
25C
56
840
10 mg/ml
4C
30
40
5 mg/ml
2-8C
91
110
8 mg/ml
-20C
79
2323
8 mg/ml
5C
28
2323
1 & 10 mg/ml
25C
72
842
1 & 10 mg/ml
4C
72
842
10 mg/ml
25C
112
1040
10 mg/ml
5C
112
1040
25 mg/ml
37C
14
484
25 mg/ml
4C
14
484
50 mg/ml
25C
415
50 mg/ml
33C
14
1475
50 mg/ml
37C
415
12 & 40 mg/ml
25C
33
0,1 mg/ml
-10C
1812
0,1 mg/ml
25C
1812
0,1 mg/ml
40C
1812
0,1 mg/ml
5C
1812
50 mg/ml
25C
28
1523
50 mg/ml
30C
21
1,44 mg/ml
21-22C
48
1520
1,44 mg/ml
23C
72
1501
1,44 mg/ml
4C
72
1501
1,44 mg/ml
4C
48
1520
25 mg/ml
25C
21
1817
25 mg/ml
31C
21
1817
25 mg/ml
4C
14
1817
5 mg/ml
25C
24
133
8,3 mg/ml
5C
112
1040
50 mg/ml
25C
56
447
50 mg/ml
25C
21
1817
50 mg/ml
31C
21
1817
10 mg/ml
22C
28
142
10 mg/ml
25C
28
844
10 mg/ml
35C
28
142
10 mg/ml
35C
28
844
10 mg/ml
4C
28
844
15 & 45 mg/ml
25C
33
50 mg/ml
22C
28
142
50 mg/ml
25C
28
844
50 mg/ml
33C
14
1475
50 mg/ml
35C
28
142
50 mg/ml
35C
28
844
50 mg/ml
37C
56
1842
Stability of mixtures
1 mg/ml
20C-23C
57
0,08 mg/ml
25C
2009
1 & 16 mg/ml
-20C
35
513
16 mg/ml
23C
513
1 mg/ml
23C
35
513
16 mg/ml
32C
513
1 mg/ml
32C
513
1 & 16 mg/ml
4C
35
513
1 & 2 mg/ml
25C
24
411
24 mg/ml
37C
163
24 mg/ml
4C
14
163
24 mg/ml
32C
14
2331
Incompatibilities
Fluorouracil : 16 mg/ml
1415
Fluorouracil : 16 mg/ml
301
Fluorouracil
Fluorouracil : 16 mg/ml
Amphotericin B liposomale : 0.83 mg/ml
Fluorouracil
Carboplatin
Fluorouracil : 1 mg/ml
Cisplatin : 0,5 mg/ml
Fluorouracil : 1 mg/ml
Cisplatin : 0,2 mg/ml
Fluorouracil
Cisplatin
Fluorouracil
Cisplatin
Fluorouracil : 0.25 mg/ml
Cytarabine : 0.4 mg/ml
Fluorouracil
Cytarabine
Fluorouracil
Cytarabine
Fluorouracil
Daunorubicin hydrochloride
Fluorouracil
Diazepam
Fluorouracil
Doxorubicin hydrochloride
Fluorouracil
Doxorubicin hydrochloride
Fluorouracil
Doxorubicin hydrochloride
Fluorouracil : 50 mg/ml
Droperidol : 2.5 mg/ml
Fluorouracil
Droperidol
Fluorouracil : 1 & 16 mg/ml
Fentanyl citrate : 12.5 g/ml
Fluorouracil : 16 mg/ml
Filgrastim : 30 g/ml
Fluorouracil
Filgrastim
Fluorouracil : 25 mg/ml
Folinate calcium : 10 mg/ml
Fluorouracil : 46.2 mg/ml
Folinate calcium : 1.5 mg/ml
Fluorouracil : 44.4 mg/ml
Folinate calcium : 2.2 mg/ml
Fluorouracil : 40 mg/ml
Folinate calcium : 4 mg/ml
Fluorouracil : 16.7 mg/ml
Folinate calcium : 13.3 mg/ml
Fluorouracil
Folinate calcium
3474
921
3474
413
413
3578
3474
431
3474
3580
3474
3474
3645
3474
3690
763
3474
514
244
3474
155
155
155
155
155
2181
Fluorouracil
Folinate calcium
Fluorouracil : 50 mg/ml
Folinate calcium
Fluorouracil : 33.3 mg/ml
Folinate calcium : 6.7 mg/ml
Fluorouracil
Gallium nitrate
Fluorouracil : 50 mg/ml
Gallium nitrate : 1 mg/ml
Fluorouracil
Idarubicin hydrochloride
Fluorouracil : 16 mg/ml
Lansoprazole : 0.55 mg/ml
Fluorouracil : 33.3 mg/ml
Levofolinate calcium : 6.7 mg/ml
Fluorouracil : 40 mg/ml
Levofolinate calcium : 4 mg/ml
Fluorouracil : 16.7 mg/ml
Levofolinate calcium : 13.3 mg/ml
Fluorouracil : 50 mg/ml
Levofolinate calcium
Fluorouracil : 44.4 mg/ml
Levofolinate calcium : 2.2 mg/ml
Fluorouracil : 46.2 mg/ml
Levofolinate calcium : 1.5 mg/ml
Fluorouracil : 25 mg/ml
Levofolinate calcium : 10 mg/ml
Fluorouracil : 0.25 mg/ml
Methotrexate sodium : 0.2 mg/ml
Fluorouracil
Methotrexate sodium
Fluorouracil
Methotrexate sodium
Fluorouracil
Metoclopramide hydrochloride
Fluorouracil
Morphine hydrochloride
Fluorouracil : 1 & 16 mg/ml
Morphine sulfate : 1 mg/ml
Fluorouracil
Morphine sulfate
Fluorouracil
Morphine sulfate
Fluorouracil
Ondansetron hydrochloride
Fluorouracil : 16 mg/ml
Ondansetron hydrochloride : 1 mg/ml
Fluorouracil
Oxaliplatin
Fluorouracil : 25 mg/ml
Topotecan : 0,056 mg/ml
3474
2130
155
3474
91
3474
1625
155
155
155
2130
155
155
155
431
3474
3637
3474
3474
513
3474
3531
3474
334
3634
1026
Fluorouracil
Vinorelbine tartrate
Fluorouracil : 16 mg/ml
Vinorelbine tartrate : 1 mg/ml
3474
84
Route of administration
References
Type
5 Journal
Publication
Stiles ML, Allen LV Jr, Prince SJ.
33 Journal
39 Journal
40 Journal
Stability of fluorouracil in polypropylene syringes and ethylene vinyl acetate infusion-pump reservoirs.
Am J Health-Syst Pharm 1996 ; 53: 1457-1458.
Dine T, Lebegue S, Benaji B, Gressier B, Segard V, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Kablan J,
Cazin M, Cazin JC.
Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and
ifosfamide) with PVC infusion bags.
57 Journal
Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site
injection with selected drugs.
84 Journal
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs
during simulated Y-site injection.
91 Journal
110 Journal
133 Journal
138 Journal
Visual compatibility of gallium nitrate with selected drugs during Y-site injection.
Am J Hosp Pharm 1993 ; 50: 1208-1210.
Precipitation of fluorouracil in elastomeric infusers with a polyisoprene reservoir and in polypropylene syringes with
an elastomeric joint.
142 Journal
155 Journal
163 Journal
Sewell GJ, Allsopp M, Collinson MP, Tyrrell C, Prentice AJ, Copplestone JA.
Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration
in continuous infusion regimens.
244 Journal
301 Journal
334 Journal
411 Journal
413 Journal
415 Journal
431 Journal
447 Laboratory
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration.
Am J Hosp Pharm 1991 ; 48: 2158-2160.
Stewart CF, Fleming RA.
Guidelines for the administration of drugs using the Home Pump/Homepump Eclipse disposable elastomeric
infusion systems
484 Journal
1998
The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under
storage and prolonged in use conditions.
513 Journal
514 Journal
763 Journal
840 Journal
Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride.
Ann Pharmacotherapy 1996 ; 30: 756-761.
Xu QA, Trissel LA, Martinez JF.
Rapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containers.
Ann Pharmacotherapy 1997 ; 31: 297-302.
Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.
Drug precipitation within IV tubing : A potential hazard of chemotherapy administration.
Cancer Treat Rep 1985 ; 69: 1325-1326.
Biondi L, Nairn JG.
842 Journal
844 Journal
921 Journal
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during
simulated Y-site administration.
1026 Journal
1040 Journal
1415 Journal
1475 Journal
1501 Journal
1520 Laboratory
1523 Laboratory
1625 Journal
1812 Journal
1817 Journal
1842 Journal
1998 Journal
2009 Journal
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs.
J Pharm Biomed Anal 1996 ; 14: 395-399.
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Int J Pharm 1999 ; 185: 113-121.
B Braun
Fresenius Kabi
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
Fuhrman LC, Godwin DA, Davis RA.
Fluorouracil precipitate.
Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride
during simulated Y-site administration.
2130 Journal
2181 Journal
2323 Journal
Long-Term Stability of 5-Fluorouracil in 0.9% Sodium Chloride after Freezing, Microwave Thawing, and
Refrigeration
2331 Journal
3474 Laboratory
3531 Laboratory
3578 Laboratory
3580 Laboratory
3634 Laboratory
3637 Laboratory
3645 Laboratory
3690 Laboratory
Doxorubicine 2 mg/mL concentrate for solution for infusion - Summary of Product Caracteristics
Accord Healthcare 2014
Dictionary
Cytostatic
Injection
Tradename
Stability in solutions
Container
Molecule
Concentration
Temperature
Storage
Length of time
References
Glass
Hour
Day
Polyvinyl chloride
Light
Glucose 5%
None
Polypropylene
Not specified
Polyethylene
Elastomer
Not specified
Stability of mixtures
Solvent
Compound
Induces
Precipitation
Incompatibilities
Route of administration
Intravenous infusion
Continuous infusion
Intra-arterial
Intravesical
Intraperitoneal
Intravitreous
Sub-conjunctival
References
Dictionary